Phosphate homeostasis, parathyroid hormone, and fibroblast growth factor 23 in stages 3 and 4 chronic kidney disease

被引:6
|
作者
Phelps, Kenneth R. [1 ,2 ]
Mason, Darius L. [1 ,2 ,3 ]
Stote, Kim S. [4 ]
机构
[1] Stratton Vet Affairs Med Ctr, Albany, NY USA
[2] Albany Med Coll, Albany, NY 12208 USA
[3] Albany Coll Pharm & Hlth Sci, Albany, NY USA
[4] SUNY Empire State Coll, Saratoga Springs, NY 12866 USA
关键词
phosphate; phosphorus; chronic kidney disease; parathyroid hormone; fibroblast growth factor 23; DIETARY PHOSPHORUS RESTRICTION; CHRONIC-RENAL-FAILURE; VITAMIN-D; SECONDARY HYPERPARATHYROIDISM; HYPER-PARATHYROIDISM; MINERAL METABOLISM; FGF23; CALCIUM; RATS; CKD;
D O I
10.5414/CN108686
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: Increased concentrations of parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) often coincide with normal serum phosphorus ([P](s)) in chronic kidney disease (CKD). We hypothesized that the phosphate concentration ([P](f)) in the cortical distal nephron (CDN) determines [PTH] and [FGF23] in this circumstance. Methods: We studied 29 patients with CKD at 4 visits and 28 controls at 1 visit. Assuming GFR = creatinine clearance (C-cr), we examined the following regressions: [P](s) on its determinants, E-P/C-cr and TRP/C-cr (P excretion and reabsorption per volume of filtrate); [PTH] and [FGF23] on [P] s and E-P/C-cr; and TRP/C-cr on [PTH] and [FGF23]. We assumed that E-P/C-cr is proportional to [P](f) in the CDN. Results: In controls, [P](s) correlated with TRP/C-cr but not E-P/C-cr. [PTH] and [FGF23] were unrelated to [P](s), E-P/C-cr, and TRP/C-cr. In CKD, [P](s) correlated with E-P/C-cr and TRP/C-cr. [PTH] correlated with [P](s) at 2 visits and with E-P/C-cr at 4; [FGF23] correlated with [P](s) and E-P/C-cr at all visits. TRP/C-cr correlated with [FGF23] and [PTH] at one visit each. Conclusions: [P](f) in the CDN, not [P](s), determined [PTH] in CKD. Because [FGF23] was consistently associated with only one determinant of [P](s), E-P/C-cr, we infer that [P](f) also determined [FGF23]. In patients with CKD, we speculate that [P](f) in the CDN regulates FGF23 synthesis at that site.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 50 条
  • [41] Cortical and Trabecular Microarchitecture Impairment Correlates with Fibroblast Growth Factor-23 and Metabolic Acidosis in Men with Stages 3 and 4 of Chronic Kidney Disease
    Paranhos-Neto, Francisco
    Lima, Guilherme
    Silva, Luciana
    Madeira, Miguel
    Mendonca, Laura
    Lima, Inaya
    Morales, Ana
    Delgado, Alvimar
    Leite Junior, Maurilo
    Gomes, Carlos
    Farias, Maria Lucia
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [42] Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
    Sugiura, Hidekazu
    Matsushita, Al
    Futaya, Mayuko
    Teraoka, Atsuko
    Akiyama, Ken-ichi
    Usui, Noriyoshi
    Nagano, Nobuo
    Nitta, Kosaku
    Tsuchiya, Ken
    PLOS ONE, 2018, 13 (03):
  • [43] The phosphate regulating hormone fibroblast growth factor-23
    Marsell, R.
    Jonsson, K. B.
    ACTA PHYSIOLOGICA, 2010, 200 (02) : 97 - 106
  • [44] Is Fibroblast Growth Factor-23 a novel marker for phosphate burden in chronic kidney disease with prognostic implications?
    Bielesz, Bernhard
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (7-8) : 194 - 197
  • [45] Is Fibroblast Growth Factor-23 a novel marker for phosphate burden in chronic kidney disease with prognostic implications?
    Bernhard Bielesz
    Wiener klinische Wochenschrift, 2010, 122 : 194 - 197
  • [46] GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease
    Canney, Mark
    Djurdjev, Ognjenka
    Tang, Mila
    Zierold, Claudia
    Blocki, Frank
    Wolf, Myles
    Levin, Adeera
    AMERICAN JOURNAL OF NEPHROLOGY, 2019, 50 (02) : 105 - 114
  • [47] Effect of a Non-Calcium-Based Phosphate Binder on Fibroblast Growth Factor 23 in Chronic Kidney Disease
    Spatz, Christin
    Roe, Kevin
    Lehman, Erik
    Verma, Navin
    NEPHRON CLINICAL PRACTICE, 2013, 123 (1-2): : 61 - 66
  • [48] Minireview: Fibroblast Growth Factor 23 in Phosphate Homeostasis and Bone Metabolism
    Hori, Michiko
    Shimizu, Yuichiro
    Fukumoto, Seiji
    ENDOCRINOLOGY, 2011, 152 (01) : 4 - 10
  • [49] Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease
    Taylor, Eric N.
    Rimm, Eric B.
    Stampfer, Meir J.
    Curhan, Gary C.
    AMERICAN HEART JOURNAL, 2011, 161 (05) : 956 - 962
  • [50] Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease
    Negri, Armando Luis
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (01) : 9 - 17